3 INHIBITORS OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT-DIRECTED GENE-EXPRESSION AND VIRUS-REPLICATION

被引：205
作者：
LI, CJ
ZHANG, LJ
DEZUBE, BJ
CRUMPACKER, CS
PARDEE, AB
机构：
[1] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV INFECT DIS,BOSTON,MA 02215
[2] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02215
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1993年 / 90卷 / 05期
关键词：
D O I：
10.1073/pnas.90.5.1839
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Transcription of type 1 human immunodeficiency virus (HIV-1) provirus is governed by the viral long terminal repeat (LTR). Drugs can block HIV-1 replication by inhibiting activity of its LTR. We report that topotecan, beta-lapachone, and curcumin are potent and selective inhibitors of HIV-1 LTR-directed gene expression, at concentrations that have minor effects on cells. At these concentrations, each drug inhibited p24 antigen production in cells either acutely or chronically infected with HIV-1. Their target is transcriptional function of the LTR.
引用
收藏
页码：1839 / 1842
页数：4
相关论文
共 50 条
  • [31] THE LONG TERMINAL REPEAT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GER ISOLATE SHOWS A DUPLICATION OF THE TAR REGION
    EMILIANI, S
    DELSERT, C
    DAVID, C
    DEVAUX, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1751 - 1752
  • [32] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT BY TRANSFORMING MUTANTS OF HUMAN P53
    SUBLER, MA
    MARTIN, DW
    DEB, S
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 103 - 110
  • [33] THE EPSTEIN-BARR-VIRUS BZLF1 GENE-PRODUCT ACTIVATES THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5' LONG TERMINAL REPEAT
    MALLON, R
    BORKOWSKI, J
    ALBIN, R
    PEPITONI, S
    SCHWARTZ, J
    KIEFF, E
    JOURNAL OF VIROLOGY, 1990, 64 (12) : 6282 - 6285
  • [34] THE EPSTEIN-BARR-VIRUS DNA-POLYMERASE TRANSACTIVATES THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 5' LONG TERMINAL REPEAT
    LIN, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) : 242 - 249
  • [35] EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 TRANSACTIVATES THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SCALA, G
    QUINTO, I
    RUOCCO, MR
    MALLARDO, M
    AMBROSINO, C
    SQUITIERI, B
    TASSONE, P
    VENUTA, S
    JOURNAL OF VIROLOGY, 1993, 67 (05) : 2853 - 2861
  • [36] ALLELIC VARIATION IN THE EFFECTS OF THE NEF GENE ON REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TERWILLIGER, EF
    LANGHOFF, E
    GABUZDA, D
    ZAZOPOULOS, E
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10971 - 10975
  • [37] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) GAG GENE-EXPRESSION BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE
    ANAZODO, MI
    WAINBERG, MA
    FRIESEN, AD
    WRIGHT, JA
    LEUKEMIA, 1995, 9 : S86 - S88
  • [38] TRANSCRIPTION FACTOR AP-2 REGULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENE-EXPRESSION
    PERKINS, ND
    AGRANOFF, AB
    DUCKETT, CS
    NABEL, GJ
    JOURNAL OF VIROLOGY, 1994, 68 (10) : 6820 - 6823
  • [39] SEQUENCES WITHIN THE FELINE IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT THAT REGULATE GENE-EXPRESSION AND RESPOND TO ACTIVATION BY FELINE HERPESVIRUS TYPE-1
    KAWAGUCHI, Y
    NORIMINE, J
    MIYAZAWA, T
    KAI, CK
    MIKAMI, T
    VIROLOGY, 1992, 190 (01) : 465 - 468
  • [40] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY A TAT-ACTIVATED, TRANSDUCED INTERFERON GENE - TARGETED EXPRESSION TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CELLS
    SU, Y
    POPIK, W
    PITHA, PM
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 110 - 121
12345